Temporal Trends in Cardiogenic Shock Complicating Acute Myocardial Infarction in South Korea
Authors:
- Pil Sang SongPSPil Sang Song
- Kye Taek AhnKAKye Taek Ahn
- Mi Joo KimMKMi Joo Kim
- Seok-Woo SeongSSSeok-Woo Seong
- Hyeon-Cheol GwonHGHyeon-Cheol Gwon
- Seung-Ho HurSHSeung-Ho Hur
- Seung-Woon RhaSRSeung-Woon Rha
- Chang-Hwan YoonCYChang-Hwan Yoon
- Seung Hun LeeSLSeung Hun Lee
- Myung Ho JeongMJMyung Ho Jeong
- Jin-Ok JeongJJJin-Ok Jeong
Open Access
- 1 January 2026
- journal article
- Published by XMLink in Korean Circulation Journal
- Vol. 56 (9) , 794
Abstract
We aimed to study temporal trends in cardiogenic shock (CS) complicating acute myocardial infarction (AMI) and assessed the predictors of shock development during hospitalization and of mortality. Data were obtained from 2 Korean AMI Registries (KAMIRs), the KAMIR-National Institutes of Health (early) and KAMIR-V (late). Patients with CS were those with CS before admission (ba-CS) and those who developed CS during admission as a complication of AMI (da-CS). Temporal trends were examined as early (2011-2015) and late (2016-2020) periods. A total of 28,990 patients was included, of whom 3,179 (11.0%) had CS. The overall prevalence of CS decreased from 12.5% to 9.6% (p for trend <0.001). Among CS patients, 1,900 (59.8% of those with CS) had ba-CS and 1,279 developed da-CS. The prevalence of both ba- (7.1% to 6.1%, p<0.001) and da-CS (5.4% to 3.6%, p<0.001) decreased, while the use of percutaneous coronary intervention increased. Over the 10-year period, in-hospital mortality rates decreased in overall CS (from 27.3% to 22.9%; p=0.004) and ba-CS (from 25.1% to 17.0%; p<0.001), but not in da-CS (from 30.3% to 32.9%; p=0.335). The decline in mortality rates of overall and ba-CS but not that of da-CS emphasizes the need for enhanced prevention strategies, early identification of development of CS after admission, and alternative therapeutic strategies for patients at high risk of CS in the acute stage of AMI.Keywords
Funding Information
- Chungnam National University Hospital (2021-CF-055)
This publication has 28 references indexed in Scilit:
- Long-Term Outcomes of Cardiogenic Shock Complicating Myocardial InfarctionJACC, 2023
- Criteria for Defining Stages of Cardiogenic Shock SeverityJACC, 2022
- Cardiogenic Shock After Acute Myocardial InfarctionJAMA, 2021
- Trends in Cardiogenic Shock Complicating Acute Myocardial InfarctionEuropean Journal of Heart Failure, 2020
- Management of cardiogenic shock complicating myocardial infarctionIntensive Care Medicine, 2018
- Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic ShockJACC, 2018
- Temporal Trends in the Epidemiology, Management, and Outcome of Patients with Cardiogenic Shock Complicating Acute Coronary SyndromesEuropean Journal of Heart Failure, 2015
- Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trialThe Lancet, 2005
- Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE Quality Improvement InitiativeAmerican Heart Journal, 2005
- Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplastyJACC, 2004